Human cytomegalovirus modulation of signal transduction

Current Topics in Microbiology and Immunology

Volumn 325, Issue , 2008, Pages 205-220

  Yurochko, A D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

CALCIUM TRANSPORT; CELL SPECIFICITY; CELL TYPE; CYTOMEGALOVIRUS INFECTION; DIPLOIDY; ENDOTHELIUM CELL; GENE EXPRESSION; HOST CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; INTEGUMENT; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VIRION; VIRUS ATTACHMENT; VIRUS GENE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHYSIOLOGY;

HUMAN HERPESVIRUS 5;

CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 48849114064     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-77349-8_12     Document Type: Review

References (91)

1. Albrecht T, Boldogh I, Fons M, AbuBakar S, Deng CZ (1990) Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology 31:68-75
2. Albrecht T, Boldogh I, Fons MP, Valyi-Nagy T (1993) Activation of proto-oncogenes and cell activation signals in the initiation and progression of human cytomegalovirus infection. In: Becker Y, Darai G, Huang ES (eds) Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, Berlin, New York, Heidelberg, pp 384-411
3. Andoniou CE, Degli-Esposti MA (2006) Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 84:99-106
4. Arena S, Benvenuti S, Bardelli A (2005) Genetic analysis of the kinome and phosphatome in cancer. Cell Mol Life Sci 62:2092-2099
5. Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162:6967-6970
6. Benedict CA, Angulo A, Patterson G, Ha S, Huang H, Messerle M, Ware CF, Ghazal P (2004) Neutrality of the canonical NFκ-B-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 78:741-750
7. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, Yurochko AD (2006) Human cytomegalovirus (HCMV) infection of endothelial cells promotes naïve monocyte extravasation and transfer of productive virus to enhance the hematogenous dissemination of HCMV. J Virol 80:11539-11555
8. Bentz GL, Yurochko AD (2008) HCMV infection of endothelial cells induces an angiogenic response through viral binding to the epidermal growth factor receptor and the β1 and β3 integrins. Proc Natl Acad Sci U S A (in press)
9. Boehme KW, Singh J, Perry ST, Compton T (2004) Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 78:1202-1211
10. Boehme KW, Guerrero M, Compton T (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177:7094-7102
11. Boyle KA, Pietropaolo RL, Compton T (1999) Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 19:3607-3613
12. Britt WJ, Mach M (1996) Human cytomegalovirus glycoproteins. Intervirology 39:401-412
13. Browne EP, Shenk T (2003) Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A 100:11439-11444
14. Cantrell SR, Bresnahan WA (2006a) Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80:6188-6191
15. Cantrell SR, Bresnahan WA (2006b) Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J Virol 79:7792-7802
16. Caposio P, Dreano M, Garotta G, Gribaudo G, Landolfo S (2004) Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. J Virol 78:3190-3195
17. Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G (2007) Activation of the virus-induced IKK/NFκ-B signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol 9: 2040-2054
18. Castillo JP, Kowalik TF (2004) HCMV infection: modulating the cell cycle and cell death. Int Rev Immunol 23:113-139
19. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347-3350
20. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77:4588-4596
21. Cooper GM, Hausman RE (2007) Cell Signaling. In: Press A (ed) The cell: a molecular approach. Sinauer Associates, Inc., Sunderland, MA, pp 599-648
22. DeMeritt IB, Yurochko AD (eds) (2006) The role of cellular transcription factors in the immediate-early stages of β-herpesvirus replication. Transworld Research Network, Kerla, India
23. DeMeritt IB, Milford LE, Yurochko AD (2004) Activation of the NFκ-B pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 78:4498-4507
24. DeMeritt IB, Podduturi JP, Tilley AM, Nogalski M, Yurochko AD (2006) Prolonged activation of NFκ-B by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 346:15-31
25. Eickhoff JE, Cotten M (2005) NFκ-B activation can mediate inhibition of human cytomegalovirus replication. J Gen Virol 86:285-295
26. Evers DL, Wang X, Huang ES (2004) Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect 6:1084-1093
27. Feire AL, Koss H, Compton T (2004) Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A 101:15470-15475
28. Feng X, Schröer J, Yu D, Shenk T (2006) Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle. J Virol 80:8371-8378
29. Gallina A, Simoncini L, Garbelli S, Percivalle E, Pedrali-Noy G, Lee KS, Erikson RL, Plachter B, Gerna G, Milanesi G (1999) Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein. J Virol 73:1468-1478
30. Gealy C, Humphreys C, Dickinson V, Stinski M, Caswell R (2007) An activation-defective mutant of the human cytomegalovirus IE2p86 protein inhibits NFκ-B-mediated stimulation of the human interleukin-6 promoter. J Gen Virol 88:2435-2440
31. Goldmacher VS, Bartle LM, Skaletskaya A, Dionne CA, Kedersha NL, Vater CA, Han JW, Lutz RJ, Watanabe S, McFarland ED, Kieff ED, Mocarski ES, Chittenden T (1999) A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A 96:12536-12541
32. Gustems M, Borst E, Benedict CA, Perez C, Messerle M, Ghazal P, Angulo A (2006) Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NFκ-B Binding Sites in the Enhancer. J Virol 80:9899-9904
33. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023-10033
34. Hwang J, Kalejta RF (2007) Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 667:334-338
35. Isaacson MK, Feire AL, Compton T (2007) The epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol 81:6241-6247
36. Isomura H, Tsurumi T, Stinski MF (2004) Role of the proximal enhancer of the major immediateearly promoter in human cytomegalovirus replication. J Virol 78:12788-12799
37. Isomura H, Stinski MF, Kudoh A, Daikoku T, Shirata N, Tsurumi T (2005) Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J Virol 79:9597-9607
38. Kalejta RF (2004) Human cytomegalovirus pp71: a new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors. J Cell Biochem 93:37-45
39. Kalejta RF, Shenk T (2002) Manipulation of the cell cycle by human cytomegalovirus. Front Biosci 7:295-306
40. Kalejta RF, Shenk T (2003a) Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100:3263-3268
41. Kalejta RF, Shenk T (2003b) The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J Virol 77:3451-3459
42. Kalejta RF, Bechtel JT, Shenk T (2003) Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23:1887-1895
43. i mediated by the 92.5-kDa putative cell membrane receptor for HCMV gp86. Am J Physiol 269: C11-C21
44. Kim HJ, Hawke N, Baldwin AS (2006) NFκ-B and IKK as therapeutic targets in cancer. Cell Death Differ 13:738-747
45. Lu M, Shenk T (1999) Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J Virol 73:676-683
46. Maidji E, Genbacev O, Chang HT, Pereira L (2007) Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol 81:4701-4712
47. Mar EC, Patel PC, Huang ES (1981) Human cytomegalovirus-associated DNA polymerase and protein kinase activities. J Gen Virol 57:149-156
48. McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS (2003) Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316:221-233
49. Melnick JL, Adam E, DeBakey ME (1993) Human cytomegalovirus and atherogenesis. In: Becker Y, Darai G, Huang ES (eds) Molecular aspects of human cytomegalovirus diseases. Springer-Verlag, Berlin, pp 80-91
50. Michelson S, Turowski P, Picard L, Goris J, Landini MP, Topilko A, Hemmings B, Bessia C, Garcia A, Virelizier JL (1996) Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J Virol 70:1415-1423
51. Mocarski ES Jr, Shenk T, Pass RF (2007) Cytomegaloviruses. In: Knipe DM, Howley PM (eds) Fields virology, vol 2. Lippincott Williams & Wilkins, Philadelphia, pp 2701-2772
52. Munger J, Yu D, Shenk T (2006) UL26-deficient human cytomegalovirus produces virions with hypophosphorylated pp28 tegument protein that is unstable within newly infected cells. J Virol 80:3541-3548
53. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK (1984) Widespread presence of histologically occult cytomegalovirus. Hum Pathol 15:430-439
54. Nogalski MT, Podduturi JP, DeMeritt IB, Milford LE, Yurochko AD (2007) The HCMV virion possesses an activated CKII that allows for the rapid phosphorylation of the inhibitor of NFκ-B, IκBα. J Virol 81:5305-5314
55. Pajovic S, Wong EL, Black AR, Azizkhan JC (1997) Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol Cell Biol 17:6459-6464
56. Patrone M, Secchi M, Bonaparte E, Milanesi G, Gallina A (2007) Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry in endothelial cells. J Virol E 81:11479-11488
57. Poole E, King CA, Sinclair JH, Alcami A (2006) The UL144 gene product of human cytomegalovirus activates NFκ-B via a TRAF6-dependent mechanism. EMBO J 25:4390-4399
58. Prichard MN, Britt WJ, Daily SL, Hartline CB, Kern ER (2005) Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol 79:15494-15502
59. Reboredo M, Greaves RF, Hahn G (2004) Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J Gen Virol 85:3555-3567
60. Romanowski MJ, Garrido-Guerrero E, Shenk T (1997) pIRS1 and pTRS1 are present in human cytomegalovirus virions. J Virol 71:5703-5705
61. Saffert RT, Kalejta RF (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863-3871
62. Schierling K, Stamminger T, Mertens T, Winkler M (2004) Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediateearly enhancer. J Virol 78:9512-9523
63. Shen CY, Ho MS, Chang SF, Yen MS, Ng HT, Huang E-S, Wu CW (1993) High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis 168:449-452
64. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 98:7140-7145
65. Sinzger C, Jahn G (1996) Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39:302-319
66. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS (2001) A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 98:7829-7834
67. Smith MS, Bentz GL, Alexander JS, Yurochko AD (2004a) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 78:4444-4453
68. Smith MS, Bentz GL, Smith PM, Bivins ER, Yurochko AD (2004b) HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)Kdependent manner. J Leukoc Biol 76:65-76
69. Smith MS, Bivins-Smith ER, Tilley AM, Bentz GL, Chan G, Minard J, Yurochko AD (2007) Roles of PI(3)K and NFκ-B in HCMV-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J Virol 81:7683-7694
70. Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259:219-246
71. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394
72. Stamminger T, Gstaiger M, Weinzierl K, Lorz K, Winkler M, Schaffner W (2002) Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J Virol 76:4836-4847
73. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511-520
74. Streblow DN, Orloff SL, Nelson JA (2001a) Do pathogens accelerate atherosclerosis? J Nutr 131:2798-2804
75. Streblow DN, Orloff SL, Nelson JA (2001b) The HCMV chemokine receptor US28 is a potential target in vascular disease. Curr Drug Targets Infect Disord 1:151-158
76. Stropes MP, Miller WE (2004) Signaling and regulation of G-protein coupled receptors encoded by cytomegaloviruses. Biochem Cell Biol 82:636-642
77. Taylor RT, Bresnahan WA (2006a) Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFκB-dependent gene expression. J Virol 80:10763-10771
78. Taylor RT, Bresnahan WA (2006b) Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 80:920-928
79. van Cleef KW, Smit MJ, Bruggeman CA, Vink C (2006) Cytomegalovirus- encoded homologs of G protein-coupled receptors and chemokines. J Clin Virol 35:343-348
80. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DGI, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78:10960-10966
81. Waldman WJ, Adams PW, Knight DA, Sedmak DD (1997) CMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro. Transplant Proc 29:1545-1546
82. Wang D, Shenk T (2005a) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79:10330-10338
83. Wang D, Shenk T (2005b) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102:18153-18158
84. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang E-S (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456-461
85. 3 is a coreceptor for human cytomegalovirus. Nat Med 11:515-521
86. Yurochko AD, Huang E-S (1999) HCMV binding to human monocytes induces immuno-regulatory gene expression. J Immunol 162:4806-4816
87. Yurochko AD, Liu DY, Eierman D, Haskill S (1992) Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA 89:9034-9038
88. Yurochko AD, Kowalik TF, Huong S-M, Huang E-S (1995) HCMV upregulates NFκ-B activity by transactivating the NFκ-B p105/p50- and p65-promoters. J Virol 69:5391-5400
89. Yurochko AD, Hwang E-S, Rasmussen L, Keay S, Pereira L, Huang E-S (1997a) The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NFκ-B during infection. J Virol 71:5051-5059
90. Yurochko AD, Mayo MW, Poma EE, Baldwin AS Jr, Huang E-S (1997b) Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J Virol 71:4638-4648
91. Zhu H, Shen Y, Shenk T (1995) Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69:7960-7970